Rare Classic Presentation of Primary Hyperparathyroidism: A Case Report and Literature Review

References

• Erickson LA, Mete O, Juhlin CC, Perren A, Gill AJ. Overview of the 2022 WHO classification of parathyroid tumors. Endocr Pathol. 2022;33(1):64–89. doi:10.1007/s12022-022-09709-1
   PubMed Web of Science ®Google Scholar
• Ahmad R, Hammond JM. Primary, secondary, and tertiary hyperparathyroidism. Otolaryngol Clin North Am. 2004;37(4):701–713. doi:10.1016/j.otc.2004.02.004
   PubMed Web of Science ®Google Scholar
• Heath H III, Hodgson SF, Kennedy MA. Primary hyperparathyroidism: incidence, morbidity, and potential economic impact in a community. N Engl J Med. 1980;302(4):189–193. doi:10.1056/NEJM198001243020402
   PubMed Web of Science ®Google Scholar
• Pradeep PV, Jayashree B, Mishra A, Mishra SK. Systematic review of primary hyperparathyroidism in India: the past, present, and the future trends. Int J Endocrinol. 2011;2011. doi:10.1155/2011/921814
   PubMed Web of Science ®Google Scholar
• Yeh MW, Ituarte PH, Zhou HC, et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab. 2013;98(3):1122–1129. doi:10.1210/jc.2012-4022
   PubMed Web of Science ®Google Scholar
• Silva BC, Bilezikian JP. Skeletal abnormalities in hypoparathyroidism and in primary hyperparathyroidism. Rev Endocr Metab Disord. 2021;22(4):789–802. doi:10.1007/s11154-020-09614-0
   PubMed Web of Science ®Google Scholar
• Sharma S, Rastogi A, Bhadada SK, et al. Prevalence and predictors of primary hyperparathyroidism among patients with urolithiasis. Endocr Pract. 2017;23(11):1311–1315. doi:10.4158/EP171759.OR
   PubMed Web of Science ®Google Scholar
• Ganesan C, Weia B, Thomas IC, et al. Analysis of primary hyperparathyroidism screening among US veterans with kidney stones. JAMA Surg. 2020;155(9):861–868. doi:10.1001/jamasurg.2020.2423
   PubMed Web of Science ®Google Scholar
• Joborn C, Hetta J, Johansson H, et al. Psychiatric morbidity in primary hyperparathyroidism. World J Surg. 1988;12:476–480. doi:10.1007/BF01655425
   PubMed Web of Science ®Google Scholar
• Bauman BD, Evasovich M, Louiselle A, et al. An occult ectopic parathyroid adenoma in a pediatric patient: a case report and management algorithm. J Pediatr Endocrinol Metab. 2017;30(9):995–999. doi:10.1515/jpem-2017-0077
   PubMed Web of Science ®Google Scholar
• Bhadada SK, Arya AK, Mukhopadhyay S, et al. Primary hyperparathyroidism: insights from the Indian PHPT registry. J Bone Miner Metab. 2018;36:238–245. doi:10.1007/s00774-017-0833-8
   PubMed Web of Science ®Google Scholar
• Agha RA, Franchi T, Sohrabi C, Mathew G. Ligne directrice SCARE 2020: mise à jour des lignes directrices du rapport sur les cas chirurgicaux de consensus (SCARE). Int J Surg. 2020;84:226–230. doi:10.1016/j.ijsu.2020.10.034
   PubMed Web of Science ®Google Scholar
• Carneiro-Pla DM, Irvin GL III, Chen H. Consequences of parathyroidectomy in patients with “mild” sporadic primary hyperparathyroidism. Surgery. 2007;142(6):795–799. doi:10.1016/j.surg.2007.07.023
   PubMed Web of Science ®Google Scholar
• Gopinath P, Mihai R. Hyperparathyroidism. Surgery (Oxford). 2011;29(9):451–458. doi:10.1016/j.mpsur.2011.06.015
   Google Scholar
• Cordellat IM. Hyperparathyroidism: primary or secondary disease?. Reumatología Clínica (English Edition). 2012;8(5):287–291. doi:10.1016/j.reuma.2011.06.001
   Google Scholar
• Conrad DN, Olson JE, Hartwig HM, Mack E, Chen H. A prospective evaluation of novel methods to intraoperatively distinguish parathyroid tissue utilizing a parathyroid hormone assay. J Surg Res. 2006;133(1):38–41. doi:10.1016/j.jss.2006.02.029
   PubMed Web of Science ®Google Scholar
• Kebede T, Hagos E. Primary hyperparathyroidism presenting with musculoskeletal manifestations in a young patient: a case report. Ethiopian Med J. 2004;42(4):299–301.
   PubMedGoogle Scholar
• Tinsae Alemayehu MD, Workeabeba Abebe MD. Case report parathyroid adenoma in an Ethiopian adolescent living with human immunodeficiency virus: a rare association. Ethiop Med J. 2019;57(2):283–285.
   Google Scholar
• Wondimu S, Nega B. The Surgical Management of Primary Hyperparathyroidism: the Experience in Tikur Anbessa Specialized Tertiary Referral and Teaching Hospital, Addis Ababa, Ethiopia. East Cent Afr J Surg. 2016;21(3):56–62. doi:10.4314/ecajs.v21i3.10
   Google Scholar
• Lundgren E, Rastad J. Diagnosis, natural history and intervention in sporadic primary hyperparathyroidism. Surg Endocrinol. 2001:137–162.
   Google Scholar
• Madkhali T, Alhefdhi A, Chen H, Elfenbein D. Primary hyperparathyroidism. Turk J Surg. 2016;32(1):58.
   Google Scholar
• Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M, Rubin MR. Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab. 2009;94(2):351–365. doi:10.1210/jc.2008-1760
   PubMed Web of Science ®Google Scholar
• Silverberg S, Bilezikian JP. Primary hyperparathyroidism. In: Primer of the Metabolic Bone Diseases and Disorders of Mineral Metabolism; 2008:302–306.
   Google Scholar
• Jacobs TP, Bilezikian JP. Rare causes of hypercalcemia. J Clin Endocrinol Metab. 2005;90(11):6316–6322. doi:10.1210/jc.2005-0675
   PubMed Web of Science ®Google Scholar
• Marcocci C, Cetani F. Primary hyperparathyroidism. N Engl J Med. 2011;365(25):2389–2397. doi:10.1056/NEJMcp1106636
   PubMed Web of Science ®Google Scholar
• Silverberg SJ. Vitamin D deficiency and primary hyperparathyroidism. J Bone Miner Res. 2007;22(S2):V100–4. doi:10.1359/jbmr.07s202
   PubMedGoogle Scholar
• Marx SJ, Attie MF, Levine MA, Spiegel AM, Downs RW JR, Lasker RD. The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds. Medicine. 1981;60(6):397–412. doi:10.1097/00005792-198111000-00002
   PubMed Web of Science ®Google Scholar
• Eastell R, Arnold A, Brandi ML, et al. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab. 2009;94(2):340–350. doi:10.1210/jc.2008-1758
   PubMed Web of Science ®Google Scholar
• Silverberg SJ, Shane E, de la Cruz L, et al. Skeletal disease in primary hyperparathyroidism. J Bone Miner Res. 1989;4(3):283–291. doi:10.1002/jbmr.5650040302
   PubMed Web of Science ®Google Scholar
• Consensus Development Conference on Diagnosis and Management of Asymptomatic Primary Hyperparathyroidism (1990, Bethesda, Md.), Potts JT. Proceedings of the NIH consensus development conference on diagnosis and management of asymptomatic primary hyperparathyroidism. Liebert; 1991.
   Google Scholar
• Al Zahrani A, Levine MA. Primary hyperparathyroidism. Lancet. 1997;349(9060):1233–1238. doi:10.1016/S0140-6736(96)06176-4
   PubMed Web of Science ®Google Scholar
• Abati A, Skarulis MC, Shawker T, Solomon D. Ultrasound-guided fine-needle aspiration of parathyroid lesions: a morphological and immunocytochemical approach. Human Pathol. 1995;26(3):338–343. doi:10.1016/0046-8177(95)90068-3
   PubMed Web of Science ®Google Scholar
• Absher KJ, Truong LD, Khurana KK, Ramzy I. Parathyroid cytology: avoiding diagnostic pitfalls. Head Neck. 2002;24(2):157–164. doi:10.1002/hed.10003
   PubMed Web of Science ®Google Scholar
• Tseng FY, Hsiao YL, Chang TC. Ultrasound-guided fine needle aspiration cytology of parathyroid lesions. Acta Cytol. 2002;46(6):1029–1036. doi:10.1159/000327103
   PubMed Web of Science ®Google Scholar
• Kumari N, Mishra D, Pradhan R, Agarwal A, Krishnani N. Utility of fine-needle aspiration cytology in the identification of parathyroid lesions. J Cytol/Ind Acad Cytol. 2016;33(1):17. doi:10.4103/0970-9371.175490
   PubMed Web of Science ®Google Scholar
• Khan A, Bilezikian J. Primary hyperparathyroidism: pathophysiology and impact on bone. Cmaj. 2000;163(2):184–187.
   PubMed Web of Science ®Google Scholar
• Consensus development conference statement. J Bone Miner Res. 1991;6(Suppl 2):S9–13. PMID: 1763674. doi:10.1002/jbmr.5650061406
   PubMedGoogle Scholar
• Wong WK, Wong NA, Farndon JR. Early postoperative plasma calcium concentration as a predictor of the need for calcium supplement after parathyroidectomy. Br J Surg. 1996;83(4):532–534. doi:10.1002/bjs.1800830433
   PubMed Web of Science ®Google Scholar
• Crea N, Pata G, Casella C, Cappelli C, Salerni B. Predictive factors for postoperative severe hypocalcaemia after parathyroidectomy for primary hyperparathyroidism. Am Surg. 2012;78(3):352–358. doi:10.1177/000313481207800347
   PubMed Web of Science ®Google Scholar
• Pizzarelli F, Fabrizi F, Postorino M, Curatola G, Zoccali C, Maggiore Q. Parathyroidectomy and blood pressure in hemodialysis patients. Nephron. 1993;63(4):384–389. doi:10.1159/000187239
   PubMed Web of Science ®Google Scholar
• Witteveen JE, Van Thiel S, Romijn JA, Hamdy NA. Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature. Eur J Endocrinol. 2013;168(3):R45–53. doi:10.1530/EJE-12-0528
   PubMed Web of Science ®Google Scholar
• Rathi MS, Ajjan R, Orme SM. A case of parathyroid carcinoma with severe hungry bone syndrome and review of literature. Exp Clin Endocrinol Diab. 2007;20:487–490. doi:10.1055/s-2007-992155
   Google Scholar
• Ahuja MM, Chopra IJ. Coexistent hyperthyroidism and hyperparathyroidism. Metabolism. 1968;17(10):854–866. doi:10.1016/0026-0495(68)90150-9
   PubMed Web of Science ®Google Scholar
• Corsello SM, Paragliola RM, Locantore P, et al. Post-surgery severe hypocalcemia in primary hyperparathyroidism preoperatively treated with zoledronic acid. Hormones. 2010;9:338–342. doi:10.14310/horm.2002.1286
   PubMedGoogle Scholar